YTHDF2 and acute myeloid leukemia: Besides, findings had uncovered that YTHDF2, an m6A reader, was markedly upregulated in human acute myeloid leukemia (AML), and targeting YTHDF2 might compromise the cancer stem cells in AML (Paris et al., 2019).